diabetic kidney disease

systematic review meta-analysis network meta-analysis

Select All mechanism All type of patient       angiotensin receptor blockerangiotensin-converting enzyme inhibitorscalcium-channel blockers amlodipineramiprilirbesartanlosartanfinerenoneolmesartan vs placebo or controlvs angiotensin-converting enzyme inhibitorsvs calcium-channel blockers      

Filter

Group by Group by... nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition MA  in first nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in second nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in third	Description Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Results Global trial result Main results All results All result tag NCT results	All cause death (8)microvascular events (5)Cardiovascular death (5)cardiovascular events (4)stroke (fatal and non fatal) (4)myocardial infarction (fatal and non fatal) (4)Non fatal stroke (2)Non fatal MI (2)Heart failure (1) Options Numeric bar chart forest plot medians
Trial	Studied trt	Control trt	patients	tags	ROB	Trial result	All cause death	microvascular events
All mechanism
not classified
NESTOR, 2004						-
Fogari, 2002	fosinopril	control				negative
DETAIL, 2004	telmisartan	enalapril			Low risk of bias	negative
DETAIL, 2004	temisartan	enalapril			Low risk of bias	negative
amlodipine
IDNT (amlodipine vs PBO), 2001	amlodipine	placebo			Low risk of bias	negative
irbesartan
IPDM (150mg), 2001	irbesartan	placebo			Low risk of bias	suggesting
IDNT (irbesartan vs pbo), 2001	irbesartan	placebo			Low risk of bias	suggesting
IDNT (irbesartan vs amlodipine), 2001	irbesartan	amlodipine			Low risk of bias	suggesting
losartan
RENAAL, 2001	losartan	placebo			Low risk of bias	suggesting
olmesartan
ORIENT    NCT	olmesartan	placebo			Low risk of bias	negative
ramipril
DIABHYCAR, 2004	ramipril	placebo			Low risk of bias	negative